RESUMEN
The human body is a reservoir of numerous micro-creatures; whose role is substantial and indispensable in the overall development of human beings. The advances in omic approaches have offered powerful means to decipher the core microbiome and metabolome diversities in a specific organ system. The establishment of lactobacilli in the female reproductive tract is thought to be a paramount prerequisite that maintains homeostatic conditions for a sustainable and healthy pregnancy. Nevertheless, a plethora of such Lactobacillus strains of vaginal source revealed probiotic phenotypes. The plummeting in the occurrence of lactobacilli in the vaginal ecosystem is associated with several adverse pregnancy outcomes (APOs). One such pathological condition is "Bacterial Vaginosis" (BV), a pathogen dominated gynecological threat. In this scenario, the ascending traffic of notorious Gram-negative/variable BV pathogens to the uterus is one of the proposed pathways that give rise to inflammation-related APOs like preterm birth. Since antibiotic resistance is aggravating among urogenital pathogens, the probiotics intervention remains one of the alternative biotherapeutic strategies to overcome BV and its associated APOs. Perhaps, the increased inclination towards the safer and natural biotherapeutic strategies rather than pharmaceutical drugs for maintaining gestational and reproductive health resulted in the use of probiotics in pregnancy diets. In this context, the current review is an attempt to highlight the microbiome and metabolites signatures of BV and non-BV vaginal ecosystem, inflammation or infection-related preterm birth, host-microbial interactions, role and effectiveness of probiotics to fight against aforesaid diseased conditions.
Asunto(s)
Nacimiento Prematuro/etiología , Probióticos/uso terapéutico , Vagina/microbiología , Vaginosis Bacteriana/complicaciones , Antibacterianos/uso terapéutico , Suplementos Dietéticos , Resistencia a Medicamentos , Disbiosis/tratamiento farmacológico , Femenino , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Homeostasis , Humanos , Recién Nacido , Lactobacillus , Interacciones Microbianas , Microbiota/efectos de los fármacos , Embarazo , Salud ReproductivaRESUMEN
The objective of this study was to assess antibiotic susceptibility among predominant Gram-negative anaerobic bacteria isolated from periodontitis patients who 5 years prior had been subject to mechanical therapy with or without adjunctive metronidazole. One pooled sample was taken from the 5 deepest sites of each of 161 patients that completed the 5 year follow-up after therapy. The samples were analyzed by culture. A total number of 85 anaerobic strains were isolated from the predominant subgingival flora of 65/161 patient samples, identified, and tested for antibiotic susceptibility by MIC determination. E-tests against metronidazole, penicillin, amoxicillin, amoxicillin + clavulanic acid and clindamycin were employed. The 73/85 strains were Gram-negative rods (21 Porphyromonas spp., 22 Prevotella/Bacteroides spp., 23 Fusobacterium/Filifactor spp., 3 Campylobacter spp. and 4 Tannerella forsythia). These were all isolated from the treated patients irrespective of therapy procedures (+/-metronidazole) 5 years prior. Three strains (Bifidobacterium spp., Propionibacterium propionicum, Parvimonas micra) showed MIC values for metronidazole over the European Committee on Antimicrobial Susceptibility Testing break point of >4 µg/mL. All Porphyromonas and Tannerella strains were highly susceptible. Metronidazole resistant Gram-negative strains were not found, while a few showed resistance against beta-lactam antibiotics. In this population of 161 patients who had been subject to mechanical periodontal therapy with or without adjunct metronidazole 5 years prior, no cultivable antibiotic resistant anaerobes were found in the predominant subgingival microbiota.
Asunto(s)
Antiinfecciosos/uso terapéutico , Periodontitis Crónica/microbiología , Farmacorresistencia Bacteriana/efectos de los fármacos , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Metronidazol/uso terapéutico , Amoxicilina/farmacología , Antibacterianos/farmacología , Periodontitis Crónica/tratamiento farmacológico , Clindamicina/farmacología , Estudios de Seguimiento , Encía/microbiología , Humanos , Pruebas de Sensibilidad Microbiana , Microbiota , Noruega , Penicilinas/farmacologíaRESUMEN
No abstract available.
Asunto(s)
Anciano , Humanos , Masculino , Antibacterianos/farmacología , Cefotaxima/análogos & derivados , Colangiopancreatografia Retrógrada Endoscópica , Cálculos Biliares/cirugía , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Infecciones por Bacterias Gramnegativas/diagnóstico , Metronidazol/uso terapéutico , Pruebas de Sensibilidad Microbiana , ARN Ribosómico 16S/química , Análisis de Secuencia de ADN , Tomografía Computarizada por Rayos XRESUMEN
During the course of our research on the lead optimisation of the NBTI (Novel Bacterial Type II Topoisomerase Inhibitors) class of antibacterials, we discovered a series of tricyclic compounds that showed good Gram-positive and Gram-negative potency. Herein we will discuss the various subunits that were investigated in this series and report advanced studies on compound 1 (GSK945237) which demonstrates good PK and in vivo efficacy properties.
Asunto(s)
Antibacterianos/farmacología , Compuestos Heterocíclicos con 3 Anillos/farmacología , Compuestos Heterocíclicos de 4 o más Anillos/química , Compuestos Heterocíclicos de 4 o más Anillos/farmacología , Inhibidores de Topoisomerasa II/química , Inhibidores de Topoisomerasa II/farmacología , Animales , Antibacterianos/química , Antibacterianos/farmacocinética , Técnicas de Química Sintética , ADN-Topoisomerasas de Tipo II/química , ADN-Topoisomerasas de Tipo II/metabolismo , Perros , Evaluación Preclínica de Medicamentos/métodos , Canal de Potasio ERG1/metabolismo , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Compuestos Heterocíclicos con 3 Anillos/síntesis química , Compuestos Heterocíclicos con 3 Anillos/química , Infecciones Neumocócicas/tratamiento farmacológico , Ratas , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones del Sistema Respiratorio/microbiología , Inhibidores de Topoisomerasa II/farmacocinéticaRESUMEN
This study assessed the subgingival occurrence of the flagellated, Gram-negative, anaerobic rod Centipeda periodontii in chronic periodontitis and periodontal health/gingivitis with species-specific nucleic acid probes, and evaluated the in vitro resistance of subgingival isolates to therapeutic levels of amoxicillin, metronidazole, and doxycycline. Subgingival plaque biofilm specimens from 307 adults with chronic periodontitis, and 48 adults with periodontal health/localized gingivitis, were evaluated with digoxigenin-labeled, whole-chromosomal, DNA probes to C. periodontii ATCC 35019 possessing a 10(4) cell detection threshold. Fifty-two C. periodontii subgingival culture isolates were assessed on antibiotic-supplemented enriched Brucella blood agar for in vitro resistance to either amoxicillin at 2 µg/ml, metronidazole at 4 µg/ml, or doxycycline at 2 µg/ml. A significantly greater subgingival occurrence of C. periodontii was found in chronic periodontitis subjects as compared to individuals with periodontal health/gingivitis (13.4 vs. 0 %, P < 0.003), although high subgingival counts of the organism (≥ 10(6) cells) were rarely detected (1.3 % of chronic periodontitis subjects). In vitro resistance was not found to amoxicillin or metronidazole, and to doxycycline in only 2 (3.9 %) of the 52 C. periodontii clinical isolates studied. These findings indicate that C. periodontii is not a major constituent of the subgingival microbiome in chronic periodontitis or periodontal health/gingivitis. The potential contribution of C. periodontii to periodontal breakdown in the few chronic periodontitis subjects who yielded high subgingival levels of the organism remains to be delineated. C. periodontii clinical isolates were susceptible in vitro to therapeutic concentrations of three antibiotics frequently used in treatment of human periodontitis.
Asunto(s)
Periodontitis Crónica/microbiología , Gingivitis/microbiología , Bacterias Anaerobias Gramnegativas/patogenicidad , Adulto , Amoxicilina/farmacología , Antibacterianos/farmacología , Biopelículas , ADN Bacteriano/análisis , Doxiciclina/farmacología , Femenino , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Bacterias Anaerobias Gramnegativas/aislamiento & purificación , Humanos , Masculino , Metronidazol/farmacología , Pruebas de Sensibilidad MicrobianaRESUMEN
AIM: this study was conducted to evaluate the antimicrobial effectiveness of 6 root canal filling materials and a negative control agent against 18 strains of bacteria isolated from infected root canals of primary molar teeth using agar diffusion assay. MATERIALS: Aloevera with sterile water Zinc oxide and Eugenol, Zinc oxide-Eugenol with aloevera, Calcium hydroxide and sterile water, Calcium hydroxide with sterile water and aloevera, Calcium hydroxide and Iodoform (Metapex) and Vaseline (Control). MIC and MBC of aloevera was calculated. RESULTS: All materials except Vaseline showed varied antimicrobial activity against the test bacterias. The zones of inhibition were ranked into 4 inhibition categories based on the proportional distribution of the data. All the 18 bacterial isolates were classified under 2 groups based on Gram positive and Gram negative aerobes. Statistical analysis was carried out to compare the antimicrobial effectiveness between materials tested with each of the bacterial groupings. CONCLUSION: Aloevera + Sterile Water was found to have superior antimicrobial activity against most of the microorganisms followed by ZOE + Aloevera, calcium hydroxide + Aloevera, ZOE, calcium hydroxide, Metapex in the descending order and Vaseline showed no inhibition.
Asunto(s)
Aloe , Antibacterianos/farmacología , Cavidad Pulpar/microbiología , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Extractos Vegetales/farmacología , Materiales de Obturación del Conducto Radicular/farmacología , Diente Primario/microbiología , Antibacterianos/administración & dosificación , Antiinfecciosos Locales/administración & dosificación , Antiinfecciosos Locales/farmacología , Hidróxido de Calcio/administración & dosificación , Hidróxido de Calcio/farmacología , Niño , Preescolar , Fístula Dental/microbiología , Necrosis de la Pulpa Dental/microbiología , Combinación de Medicamentos , Humanos , Hidrocarburos Yodados/administración & dosificación , Hidrocarburos Yodados/farmacología , Ensayo de Materiales , Pruebas de Sensibilidad Microbiana , Diente Molar/microbiología , Absceso Periapical/microbiología , Vaselina/farmacología , Extractos Vegetales/administración & dosificación , Aceites de Silicona/administración & dosificación , Aceites de Silicona/farmacología , Cemento de Óxido de Zinc-Eugenol/administración & dosificación , Cemento de Óxido de Zinc-Eugenol/farmacologíaRESUMEN
The objective of the present study was to investigate the inhibitory effect of a commercially available essential oil-containing mouth rinse 12 hours after a single rinse and two weeks of twice daily rinsing, on volatile sulphur compounds (VSC) producing bacteria on the tongue. The study was a randomized, double-blind, controlled crossover design. Thirty-six healthy subjects, aged 20-48 years, volunteered to participate in the study. Subjects were randomly assigned to rinse twice daily with either an essential oil-containing mouth rinse (Cool Mint Listerine Antiseptic) or a negative control rinse. Bacteria samples were taken from the dorsum of the tongue at baseline, after the first rinse and two weeks later. They were plated on OOPS medium to enumerate the VSC-producing bacteria. Intergroup comparisons of log10 transformed colony-forming units of the samples were made using analysis of covariance. Each comparison was performed at a 5% significance level. The mean VSC-producing bacteria in subjects using the essential oil mouth rinse were significantly lower than those using the control rinse twice daily. In healthy subjects, rinsing with an essential oil-containing mouth rinse can have a significant effect on VSC-producing bacteria on the tongue and may be useful for controlling intrinsic oral malodor over prolonged periods.
Asunto(s)
Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Halitosis/tratamiento farmacológico , Halitosis/microbiología , Antisépticos Bucales/uso terapéutico , Aceites Volátiles/uso terapéutico , Lengua/microbiología , Adulto , Recuento de Colonia Microbiana , Estudios Cruzados , Método Doble Ciego , Femenino , Bacterias Anaerobias Gramnegativas/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Antisépticos Bucales/química , Compuestos de Azufre/metabolismo , Bacterias Reductoras del Azufre , Adulto JovenRESUMEN
In the present study, EA-CATH1 and EA-CATH2 were identified from a constructed lung cDNA library of donkey (Equus asinus) as members of cathelicidin-derived antimicrobial peptides, using a nested PCR-based cloning strategy. Composed of 25 and 26 residues, respectively, EA-CATH1 and EA-CATH2 are smaller than most other cathelicidins and have no sequence homology to other cathelicidins identified to date. Chemically synthesized EA-CATH1 exerted potent antimicrobial activity against most of the 32 strains of bacteria and fungi tested, especially the clinically isolated drug-resistant strains, and minimal inhibitory concentration values against Gram-positive bacteria were mostly in the range of 0.3-2.4 microg mL(-1). EA-CATH1 showed an extraordinary serum stability and no haemolytic activity against human erythrocytes in a dose up to 20 microg mL(-1). CD spectra showed that EA-CATH1 mainly adopts an alpha-helical conformation in a 50% trifluoroethanol/water solution, but a random coil in aqueous solution. Scanning electron microscope observations of Staphylococcus aureus (ATCC2592) treated with EA-CATH1 demonstrated that EA-CATH could cause rapid disruption of the bacterial membrane, and in turn lead to cell lysis. This might explain the much faster killing kinetics of EA-CATH1 than conventional antibiotics revealed by killing kinetics data. In the presence of CaCl(2), EA-CATH1 exerted haemagglutination activity, which might potentiate an inhibition against the bacterial polyprotein interaction with the host erythrocyte surface, thereby possibly restricting bacterial colonization and spread.
Asunto(s)
Péptidos Catiónicos Antimicrobianos/genética , Péptidos Catiónicos Antimicrobianos/farmacología , Equidae/genética , Secuencia de Aminoácidos/genética , Animales , Péptidos Catiónicos Antimicrobianos/química , Péptidos Catiónicos Antimicrobianos/metabolismo , Proteínas Sanguíneas/genética , Cloruro de Calcio/farmacología , Clonación Molecular , ADN Complementario/genética , Eritrocitos/citología , Eritrocitos/efectos de los fármacos , Hongos/efectos de los fármacos , Biblioteca de Genes , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Hemaglutinación/efectos de los fármacos , Hemólisis/efectos de los fármacos , Humanos , Concentración de Iones de Hidrógeno , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Filogenia , Precursores de Proteínas/genética , Estructura Secundaria de Proteína , Conejos , Homología de Secuencia de Aminoácido , Suero/metabolismo , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/ultraestructura , CatelicidinasRESUMEN
INTRODUCTION: Obligate anaerobes are closely involved in the pathogenesis of oral and focal infections. The objective of this study was to evaluate the susceptibility profiles of obligate anaerobes of oral origin to telithromycin (TLM), moxifloxacin (MXF), and other antibiotics that are commonly used in dentistry. METHODS: The study sample comprised 172 obligate anaerobes isolated from the saliva of 43 adult volunteers. The minimum inhibitory concentrations (MICs) were determined by the agar dilution technique in Brucella agar medium supplemented with vitamin K, haemin and 5% (volume/volume) laked sheep blood, and incubated under anaerobic conditions. The Clinical and Laboratory Standards Institute methodology was followed and its criteria were used for the qualitative interpretation of the results. The antibiotics evaluated were: amoxicillin (AMX), amoxicillin-clavulanic acid (AMX-CLA), clindamycin (CM), metronidazole (MTZ), azithromycin (AZM), TLM and MXF. RESULTS: Resistance to AMX (MIC(90) > or = 16 mg/l) was observed in 45.3% of the obligate anaerobes and resistance to CM (MIC(90) > or = 16 mg/l) was found in 18.6%. All the isolates were sensitive to MTZ (MIC(90) = 1 mg/l) and 98.8% were sensitive to AMX-CLA (MIC(90) = 2 mg/l). The MIC(90) values for AZM, TLM and MXF were > or =16, > or =8 and > or =2 mg/l, respectively. CONCLUSION: Pathogenic, opportunistic and non-pathogenic obligate anaerobes showed high percentages of resistance to AMX and CM, and high MIC values for AZM in the absence of recently administered antibiotics. MXF showed a higher activity than TLM, similar to that detected for AMX-CLA and MTZ. In consequence, MXF could represent a possible alternative antimicrobial against obligate anaerobes of oral origin, particularly in those patients with allergy, intolerance or lack of response to AMX-CLA or MTZ.
Asunto(s)
Antibacterianos/farmacología , Compuestos Aza/farmacología , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Cetólidos/farmacología , Periodontitis/microbiología , Quinolinas/farmacología , Adulto , Amoxicilina/farmacología , Combinación Amoxicilina-Clavulanato de Potasio/farmacología , Antiinfecciosos/farmacología , Azitromicina/farmacología , Sangre , Clindamicina/farmacología , Medios de Cultivo , Farmacorresistencia Bacteriana , Fluoroquinolonas , Hemina , Humanos , Metronidazol/farmacología , Pruebas de Sensibilidad Microbiana , Moxifloxacino , Resistencia a las Penicilinas , Saliva/microbiología , Vitamina KRESUMEN
OBJECTIVES: Retapamulin is the first agent of the pleuromutilin class formulated as a topical antibacterial for treating skin infections. The aim of this study was to determine the antimicrobial activity of retapamulin by determining the minimal inhibitory concentration (MIC) values of this new drug and comparators against a wide range of anaerobic bacteria of human origin. METHODS: The in vitro activity of retapamulin and six comparators (amoxicillin, amoxicillin/clavulanic acid, ceftriaxone, imipenem, clindamycin and metronidazole) was evaluated against 232 anaerobic clinical isolates. MICs were determined by the CLSI reference agar dilution method (M11-A6). RESULTS: Ceftriaxone, clindamycin and amoxicillin/clavulanic acid resistance rates were 54%, 42% and 9.6%, respectively, within the Bacteroides fragilis group. Despite high resistance rates to various antibiotics, retapamulin inhibited 37/52 (71%) strains of the B. fragilis group and 85/87 (98%) of the other Gram-negative bacilli at a concentration of 2 mg/L or less. All the investigated strains of Clostridium perfringens were inhibited by 1 mg/L retapamulin. Three strains of C. difficile and one strain of C. clostridioforme demonstrated decreased susceptibility to retapamulin. Based on inhibitory concentrations, retapamulin was more active than clindamycin, metronidazole and ceftriaxone against Propionibacterium acnes and anaerobic Gram-positive cocci, as all isolates were inhibited by Asunto(s)
Antibacterianos/farmacología
, Antiinfecciosos Locales/farmacología
, Bacterias Anaerobias/efectos de los fármacos
, Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología
, Enfermedades Cutáneas Infecciosas/tratamiento farmacológico
, Bacteroides fragilis/efectos de los fármacos
, Diterpenos
, Bacterias Anaerobias Gramnegativas/efectos de los fármacos
, Bacterias Grampositivas/efectos de los fármacos
, Pruebas de Sensibilidad Microbiana
RESUMEN
Propolis collected from a cerrado area in Minas Gerais State, Brazil, was subjected to chromatography on silica gel column and to partition between immiscible solvents. Propolis aqueous-ethanolic extract and fractions obtained were tested for inhibitory activity against periodontitis-causing bacteria. All of the assayed bacterium species were susceptible to propolis extract. The two fractionation methodologies yielded fractions which were active against bacteria, with minimum inhibitory concentrations (MIC) ranging from 64 to 1024 microg/ml. TLC and HPLC analyses of the extract and of active fractions showed the presence of phenolic compounds of varied polarity. None of the assayed fractions was more active than the extract, suggesting that the antibacterial activity is probably due to the synergistic effect of several compounds.
Asunto(s)
Antibacterianos/farmacología , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Infecciones por Bacterias Gramnegativas/microbiología , Periodontitis/microbiología , Própolis/farmacología , Antibacterianos/química , Brasil , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Própolis/química , Solventes/químicaRESUMEN
PURPOSE: To evaluate a new improved method of microbial analysis in a cross-over clinical study by investigating the efficacy of a single application of an essential oil-containing (EOC) dentifrice as compared to its vehicle control (VC) over a 6-hr period. MATERIALS AND METHODS: Acrylic stents with retention areas for 7, 3 mm x 3 mm hydroxyapatite (HA) squares were fabricated for 12 subjects. 30 min following stent placement, one HA square was removed and sampled for viable microflora. After stent replacement, subjects were assigned either the EOC dentifrice or its VC and brushed under supervision for 1 min. Stents remained in place for the next 6 hrs. A HA square was removed at hourly intervals for 6 hrs following brushing. The microflora was analyzed for total anaerobes on Schaedler's media, for total gram-negative anaerobes on Schaedler-NV selective media, and for total Fusobacterium species on CVE selective media. Plates were incubated anaerobically at 37 degrees C for 2-5 days. Colony forming units were calculated. For each time point, pairwise t-tests were performed using the adjusted means and the pooled error term from the analysis of variance (ANOVA). RESULTS: Treatment with the EOC dentifrice resulted in a statistically reduced plaque growth. Differences were seen as reductions in: (1) total gram-negative anaerobes seen from 1-6 hrs (P < or = 0.011), (2) total anaerobic bacteria which achieved significance at 3 hrs and continued through 6 hrs (P < or = 0.005), and (3) Fusobacterium species as seen from 4-6 hrs (P < or = 0.002).
Asunto(s)
Antiinfecciosos Locales/uso terapéutico , Bacterias/efectos de los fármacos , Placa Dental/microbiología , Dentífricos/uso terapéutico , Aceites Volátiles/uso terapéutico , Adulto , Análisis de Varianza , Bacterias/clasificación , Bacterias Anaerobias/efectos de los fármacos , Bacterias Anaerobias/crecimiento & desarrollo , Recuento de Colonia Microbiana , Estudios Cruzados , Durapatita , Femenino , Estudios de Seguimiento , Fusobacterium/efectos de los fármacos , Fusobacterium/crecimiento & desarrollo , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Bacterias Anaerobias Gramnegativas/crecimiento & desarrollo , Humanos , Modelos Lineales , Masculino , Persona de Mediana Edad , Vehículos Farmacéuticos , Tamaño de la Muestra , Estadística como Asunto , Stents , Cepillado DentalRESUMEN
Dental plaque stability depends on bacterial adhesion to acquired pellicle, and on interspecies adhesion (or coaggregation). A high-molecular-weight cranberry constituent at 0.6 to 2.5 milligrams per milliliter reversed the coaggregation of 49 (58 percent) of 84 coaggregating bacterial pairs tested. It acted preferentially on pairs in which one or both members are gram-negative anaerobes frequently involved in periodontal diseases. Thus, the anticoaggregating cranberry constituent has the potential for altering the subgingival microbiota, resulting in conservative control of gingival and periodontal diseases. However, the high dextrose and fructose content of the commercially available cranberry juice makes it unsuitable for oral hygiene use, and the beneficial effect of the high-molecular-weight constituent requires animal and clinical studies.
Asunto(s)
Adhesión Bacteriana/efectos de los fármacos , Placa Dental/microbiología , Frutas , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Extractos Vegetales/farmacología , Película Dental , Ecosistema , Electroforesis en Gel de Poliacrilamida , Frutas/química , Bacterias Anaerobias Gramnegativas/fisiología , Humanos , Peso MolecularRESUMEN
Previous trials had indicated that various schedules of sub-antimicrobial doxycycline significantly reduced gingival crevicular fluid (GCF) collagenase activity in adult patients with periodontitis with no evidence of emergent tetracycline-resistant (Tcr) marker oral flora. The purpose of this nine-month study was to expand these observations, emphasizing newer microbial diagnostic methods. Subgingival paper point samples were obtained at baseline (BL), 3, 6, and 9 months. Four subject treatment groups in a double-blind design were evaluated by mechanical scaling and root planing (SRP) and/or 20 mg doxycycline BID (Periostat). Thirty-eight patients entered the study at baseline (BL). Dark-field microscopy on 260 samples showed that morphotype distribution was independent of treatment schedule. Culture analysis of the 3 most prevalent isolates recovered showed that Streptococcus and Prevotella species accounted for approximately 85% of the 724 cultures. There did not appear to be any overgrowth or replacement by opportunistic oral flora. Of 658 susceptibility patterns evaluated by Etest, the MIC50/90 and mode MIC showed stable patterns, independent of treatment group. Our findings were different from those of previously published reports, but may be partly explained by the lack of universally standardized methods in oral microbiology and interpretive criteria for susceptibility testing.
Asunto(s)
Antibacterianos/farmacología , Doxiciclina/farmacología , Periodontitis/tratamiento farmacológico , Periodontitis/microbiología , Adulto , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Quimioterapia Adyuvante , Terapia Combinada , Profilaxis Dental , Método Doble Ciego , Doxiciclina/administración & dosificación , Doxiciclina/uso terapéutico , Farmacorresistencia Microbiana , Ecosistema , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Levaduras/efectos de los fármacosRESUMEN
Periodontal diseases essentially comprise a group of oral infections whose primary aetiological factor is dental plaque. Removal of the cause (and its effects) is the primary aim of both non-surgical and surgical treatment regimens, although the infective nature of the diseases has led to the widespread use of antimicrobials as an adjunct to mechanical debridement. The tetracyclines are primarily bacteriostatic agents that are effective against many Gram-negative species including putative periodontopathogens such as Actinobacillus actinomycetemcomitans (A.a.). The proven efficacy of this group of drugs in the management of periodontal diseases may be related not only to their antibacterial actions, but to a number of additional properties that have been recently identified. These include collagenase inhibition, anti-inflammatory actions, inhibition of bone resorption and their ability to promote the attachment of fibroblasts to root surfaces. Consequently, tetracyclines have also been used as an adjunct to bone grafting in periodontal defects, and as agents for 'conditioning' root surfaces to enhance the regeneration of periodontal tissues. When tetracyclines are taken orally, consideration must be given both to the potential unwanted effects and to interactions with other drugs that are taken concurrently. Such problems are minimised however, when the drugs are incorporated into controlled, slow-release formulations which are currently being researched and marketed for intra-oral use.
Asunto(s)
Enfermedades Periodontales/tratamiento farmacológico , Tetraciclinas/uso terapéutico , Periodontitis Agresiva/tratamiento farmacológico , Pérdida de Hueso Alveolar/prevención & control , Animales , Adhesión Celular/efectos de los fármacos , Enfermedad Crónica , Fibroblastos/fisiología , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Humanos , Inhibidores de la Metaloproteinasa de la Matriz , Pruebas de Sensibilidad Microbiana , Enfermedades Periodontales/microbiología , Periodontitis/tratamiento farmacológico , Resistencia a la Tetraciclina , Tetraciclinas/farmacología , Raíz del Diente/efectos de los fármacosRESUMEN
Cicer milkvetch (Astragalus cicer L.) is a perennial legume used as a pasture or rangeland plant for ruminants. A study was undertaken to determine whether reported variations in its ruminal digestibility may be related to the presence of an antinutritive material. In vitro fermentation of neutral detergent fiber (NDF) of cicer milkvetch by mixed rumen microflora was poorer than was the fermentation of NDF in alfalfa (Medicago sativa L.). Fermentation of cicer milkvetch NDF was improved by preextraction of the ground herbage with water for 3 h at 39 degrees C. Such water extracts selectively inhibited in vitro fermentation of pure cellulose by mixed ruminal microflora and by pure cultures of the ruminal bacteria Ruminococcus flavefaciens FD-1 and Fibrobacter succinogenes S85. Inhibition of the cellulose fermentation by mixed ruminal microflora was dependent upon the concentration of cicer milkvetch extract and was overcome upon prolonged incubation. Pure cultures exposed to the extract did not recover from inhibition, even after long incubation times, unless the inhibitory agent was removed (viz., by dilution of inhibited cultures into fresh medium). The extract did not affect the fermentation of cellobiose by R. flavefaciens but did cause some inhibition of cellobiose fermentation by F. succinogenes. Moreover, the extracts did not inhibit hydrolysis of crystalline cellulose, carboxymethyl cellulose, or p-nitrophenylcellobioside by supernatants of these pure cultures of cellulolytic bacteria or by a commercial cellulase preparation from the fungus Trichoderma reesei. The agent caused cellulose-adherent cells to detach from cellulose fibers, suggesting that the agent may act, at least in part, by disrupting the glycocalyx necessary for adherence to, and rapid digestion of, cellulose.
Asunto(s)
Celulosa/metabolismo , Fabaceae/química , Fermentación/efectos de los fármacos , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Cocos Grampositivos/efectos de los fármacos , Plantas Medicinales , Rumen/microbiología , Animales , Bovinos , Bacterias Anaerobias Gramnegativas/metabolismo , Cocos Grampositivos/metabolismo , Microscopía Electrónica de Rastreo , Extractos Vegetales/química , Extractos Vegetales/farmacologíaRESUMEN
The prevalence and in vitro antimicrobial sensitivity of isolates of enteric rods and pseudomonads was examined in 844 adult periodontitis patients. These organisms were recovered from 13.5% of the study subjects. Ciprofloxacin exhibited the highest inhibitory activity of the 14 oral antimicrobial agents tested. Beta-lactam antibiotics were largely ineffective, and tetracycline failed to inhibit most Pseudomonas species. In vitro sensitivity data suggest that a subgingival microbiota comprising mainly streptococci would result from therapy that combined ciprofloxacin and metronidazole. Since streptococci may inhibit the growth of several putative periodontal pathogens, populations of "beneficial" streptococci in the periodontal pocket might constitute a very attractive therapeutic outcome. Controlled clinical studies are needed to clarify the possible role of ciprofloxacin in the treatment of destructive periodontitis.
Asunto(s)
Ciprofloxacina/uso terapéutico , Enterobacteriaceae/efectos de los fármacos , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Periodontitis/tratamiento farmacológico , Periodontitis/microbiología , Pseudomonas/efectos de los fármacos , Adulto , Humanos , Metronidazol , Pruebas de Sensibilidad Microbiana , StreptococcusAsunto(s)
Infecciones Bacterianas/tratamiento farmacológico , Antibacterianos/uso terapéutico , Infecciones Bacterianas/diagnóstico , Infecciones Bacterianas/microbiología , Infección Hospitalaria/diagnóstico , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/microbiología , Bacterias Aerobias Gramnegativas/efectos de los fármacos , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Humanos , Oxigenoterapia Hiperbárica , Pruebas de Sensibilidad Microbiana , Infección de la Herida Quirúrgica/diagnóstico , Infección de la Herida Quirúrgica/tratamiento farmacológico , Infección de la Herida Quirúrgica/microbiologíaRESUMEN
The in vitro activity of norfloxacin (MK366) against 477 aerobic gram-negative and gram-positive clinical isolates was compared to that of nalidixic acid, nitrofurantoin, ampicillin, cephalexin, trimethoprim, sulfamethoxazole, and the combination trimethoprim-sulfamethoxazole. Norfloxacin was more active than the other agents against all gram-negative organisms tested. Minimal inhibitory concentrations (MICs) of Pseudomonas aeruginosa were less than or equal to 0.125-32 mg/l with 90% inhibited (MIC90) by 4 mg/l; MICs of the Enterobacteriaceae including Serratia marcescens were less than or equal to 0.125-8 mg/l with an MIC90 of less than or equal to 4 mg/l. There was also excellent activity against the gram-positive cocci including Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophyticus and the enterococci, with MICs less than or equal to 0.125-4 mg/l and an MIC90 less than or equal to 4 mg/l. Only 8 of 477 organisms were norfloxacin-resistant (MIC greater than or equal to 16 mg/l): 3 of 100 Pseudomonas aeruginosa, 3 of 10 Pseudomonas maltophilia and 2 of 15 Streptococcus bovis strains. In contrast, 97% of the gram-positive cocci and 49% of the gram-negative bacilli were nalidixic acid-resistant (MIC greater than or equal to 32 mg/l). Norfloxacin shows excellent activity against a wide range of bacteria and merits further study as a urinary antibacterial agent.